bpc 157 news 2026 NBC | The claims surrounding peptides are sweeping: They're promoted as treatments for everything from faster healing to younger-looking skin, The Hidden Risks of BPC‑157:

Use modification 59 only when documentation demonstrates that the injection is independent of any services delivered during the visit

Read Announcement View Product Photos Summary Company Announcement Date: FDA Publish Date: Product Type: Drugs Reason for Announcement: Recall Reason DescriptionProducts are out of specification Company Name: Olympia Pharmacy Brand Name: Brand Name(s)Olympia Pharmaceuticals Product Description: Product DescriptionCompounded Injectables Company Announcement Olympia Pharmacy is voluntarily recalling 11 specific lots of Trimix Formulas F-9, T-105, SB-4, Sermorelin, Sincalide, Hydroxocobalamin, and NAD, compounded injectables to the consumer level

Wilding JPH et al

Combined upper and lower GI endoscopy with biopsy remains the diagnostic cornerstone in atypical IBD presentations

believes it is important that all Glastonbury patients understand that while the results are very promising, BPC-157 Peptide Therapy is cutting-edge and is not yet considered a mainstream treatment